Sagent Pharmaceuticals | search
Click here to view Sagent Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Who We Are - Sagent PharmaSAGENT is a customer-focused company, delivering an extensive portfolio of injectable products and fulfilling the evolving needs of the patients we serve through our unique network of global resources.
- Eye on Pharma: Sagent Acquires US Site to Manufacture Nichi-Iko BiosimilarsSagent Pharmaceuticals, a division of Nichi-Iko Pharmaceutical Co Ltd, announced earlier this month that it has purchased an FDA-approved manufacturing site in Raleigh, North Carolina, from Xellia Pharmaceuticals. The site is capable of approving both small-molecule drugs and biologics.
- Sagent Pharmaceuticals Company Profile 2024: Valuation, Investors ...Information on acquisition, funding, investors, and executives for Sagent Pharmaceuticals. Use the PitchBook Platform to explore the full profile. Request a free trial Log in
- Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for ...TOKYO & SCHAUMBURG, Ill.–(BUSINESS WIRE)– Nichi-Iko Pharmaceutical Co., Ltd (TSE:4541) and Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) today announced that they have entered into a definitive merger agreement under which Nichi-Iko will acquire Sagent via an all-cash tender offer (the “Tender Offer”) followed by a second-step merger, for ...
- Sagent PharmaceuticalsThe SAGENT logo, SAGENT, SAGENT Pharmaceuticals and PreventIV Measures are registered trademarks of Sagent Pharmaceuticals. © 2024 Sagent Pharmaceuticals
More
